30 May 2021

A new paper by Thomas Piketty makes the rise of right-wing populism look like a historical inevitability

From The Economist: You could fill a small library with book on RIGHT-WING POPULISM.
Some authors argue that these movements emerged in reaction to relatively recent events, such as the financial crisis of 2007-09 or the advent of social media.
Others look to longer-lasting regional trends, like European integration or racial politics in America
"Thomas Piketty, an economist, became famous for a book that analysed 200 years of data on wealth inequality in a wide range of countries. This month he published a paper, co-written by Amory Gethin and Clara Martínez-Toledano, which applies a similar approach to the relationship between demography and ideology.
Source: “Brahmin Left versus Merchant Right”
by Amory Gethin, Clara Martínez-Toledano and Thomas Piketty (working paper, 2021)
Its findings imply that the electoral victories of Donald Trump and the Brexit campaign in 2016 were not an abrupt departure from precedent, but rather the consequence of a 60-year-old international trend.
In a paper in 2018 Mr Piketty noted that elites in Britain, France and America were split between intellectuals who backed left-of-centre parties—he dubbed them the “Brahmin left”—and businesspeople who preferred right-wing ones (the “merchant right”).
Brahmins v merchants
Educated voters’ leftward shift is surprisingly old and international
May 29th 2021
His new work expands this study from three Western democracies to 21.
It combines data on parties’ policy positions with surveys that show how vote choices varied between demographic groups.

Source: “Brahmin Left versus Merchant Right”, by Amory Gethin, Clara Martínez-Toledano and Thomas Piketty (working paper, 2021)

This article appeared in the Graphic detail section of the print edition under the headline "Brahmins v merchants"

========================================================================

Listen to this story

Enjoy more audio and podcasts on iOS or Android.

More

No comments: